PDCD1 and colorectal cancer: The critical role of TMB is obvious within molecular subtypes of the same kind of tumor; for example, colorectal cancer patients with tumors demonstrating microsatellite instability or deficient mismatch repair and intact mismatch repair have a 40% and 0% response following anti-PD-1 therapy, respectively (47).